China National Accord Medicines Corporation Ltd. (200028.SZ) SHZ

Currency In HKD

AD

Valuation

Market Cap11.69B
Enterprise Value18.55B
P/E Ratio10.64
PEG Ratio0.13
Price/Sales Ratio0.14
Price/Book Ratio0.66
Enterprise/Revenue0.25
Enterprise/EBITDA-1.2

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin-0.22
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.06

Income Statement

Revenue73.42B
Revenue/Share114.64
Gross Profit7.84B
EBITDA3.06B
Net Income1.11B
Diluted EPS1.03

Balance Sheet

Total Cash5.18B
Total Cash/Share8.15
Total Debt3.38B
Total Debt/Equity0.69
Current Ratio1.56
Book Value Per Share34.47

Price History

52-Week Change-4.09
52-Week High12.81
52-Week Low11.5
Moving Average 50 Days11.97
Moving Average 200 Days12.35

Statistics

Average Volume161,763
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield3.16
Payout Ratio0.47
Last Split Factor10:11
Last Split DateJune 26, 2026
AD